Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)
CUSIP: 28036F105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 105,503,387
- Total 13F shares
- 101,617,706
- Share change
- +9,950,302
- Total reported value
- $1,830,101,707
- Put/Call ratio
- 12%
- Price per share
- $18.01
- Number of holders
- 138
- Value change
- +$179,027,088
- Number of buys
- 88
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28036F105:
Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
14%
|
15,021,721
|
$273,996,191 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
8.4%
|
8,909,091
|
$162,501,820 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
6%
|
6,365,724
|
$116,110,807 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.5%
|
5,840,059
|
$106,522,676 | — | 31 Mar 2024 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,071,703
|
$95,781,722 | — | 14 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.9%
|
5,167,006
|
$94,246,190 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
4,017,433
|
$73,277,978 | — | 31 Mar 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
3.2%
|
3,339,146
|
$60,906,023 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.1%
|
3,303,567
|
$60,257,062 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.8%
|
3,006,534
|
$54,839,180 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.7%
|
2,874,586
|
$52,432,449 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
2,719,291
|
$49,599,868 | — | 31 Mar 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.3%
|
2,446,373
|
$44,621,844 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.2%
|
2,319,646
|
$42,310,343 | — | 31 Mar 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
2.2%
|
2,272,728
|
$41,454,559 | — | 31 Mar 2024 | |
| VR Adviser, LLC |
13F
|
Company |
1.7%
|
1,818,182
|
$33,163,640 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.7%
|
1,805,312
|
$32,897,580 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.7%
|
1,747,844
|
$31,880,674 | — | 31 Mar 2024 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
1.5%
|
1,553,661
|
$28,338,777 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,369,897
|
$24,991,047 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,267,819
|
$23,125,019 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.2%
|
1,250,385
|
$22,807,022 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
1,211,476
|
$22,097,322 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.77%
|
811,718
|
$14,805,736 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.63%
|
665,000
|
$12,129,600 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.62%
|
653,653
|
$11,922,631 | — | 31 Mar 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.58%
|
608,012
|
$11,090,139 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.53%
|
559,334
|
$10,202,252 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.5%
|
532,255
|
$9,708,331 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.47%
|
499,520
|
$9,111,245 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.47%
|
497,162
|
$9,068,235 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.45%
|
473,680
|
$8,639,923 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.45%
|
472,903
|
$8,625,751 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.42%
|
441,259
|
$8,048,564 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.38%
|
405,132
|
$7,389,608 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.37%
|
392,735
|
$7,163,486 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.36%
|
374,718
|
$6,834,856 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.32%
|
338,004
|
$6,165,193 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.31%
|
329,000
|
$6,000,960 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.29%
|
306,197
|
$5,585,033 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.28%
|
299,288
|
$5,459,013 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.28%
|
293,265
|
$5,349,154 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.27%
|
284,600
|
$5,191,104 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
212,265
|
$3,871,714 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.17%
|
180,911
|
$3,299,817 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
175,901
|
$3,208,434 | — | 31 Mar 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.12%
|
126,332
|
$2,304,296 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.1%
|
103,208
|
$1,882,514 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
92,400
|
$1,685,376 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
87,244
|
$1,591,331 | — | 31 Mar 2024 |
Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) as of Q2 2024
As of 30 Jun 2024,
Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,617,706 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Novo Holdings A/S, BlackRock Inc., BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, Frazier Life Sciences Management, L.P., Cormorant Asset Management, LP, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
138
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
126
Q2 2024 holders
138
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.